Article
The potential and challenges of alternative sources of β cells for the cure of type 1 diabetes
1 Mar 2018
Abstract excerpt
The experience in the field of islet transplantation shows that it is possible to replace β cells in a patient with type 1 diabetes (T1D), but this cell therapy is limited by the scarcity of organ donors and by the danger associated to the immunosuppressive drugs. Stem cell therapy is becoming a concrete opportunity to treat various diseases. In particular, for a disease like T1D, caused by the loss of a single...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.